Vimarsana
Biggest News Aggregation in the World

Page 5 - V Imaging News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from V Imaging. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In V Imaging Today - Breaking & Trending Today

New AHA Statement on AI in Cardiovascular Imaging - Vimarsana News

New AHA Statement on AI in Cardiovascular Imaging

Artificial intelligence has the potential to add value to cardiac imaging at every step of the patient journey, the AHA said in a new scientific statement.

What's the Best Antithrombotic Therapy Post TMVR? - Vimarsana News

What's the Best Antithrombotic Therapy Post TMVR?

New observational data suggested direct oral anticoagulants may be the optimal antithrombotic regime after transcatheter mitral valve replacement; randomized trials were needed.

New AHA Focused Update on Adult Advanced CV Life Support - Vimarsana News

New AHA Focused Update on Adult Advanced CV Life Support

The update includes new recommendations on temperature management and percutaneous coronary angiography in adults suffering cardiac arrest.

Positive Topline Results for SEQUOIA-HCM Trial in OHCM - Vimarsana News

Positive Topline Results for SEQUOIA-HCM Trial in OHCM

Preliminary results of the pivotal phase 3 trial show benefit of the cardiac myosin inhibitor, aficamten, in obstructive hypertrophic cardiomyopathy.

FDA Expands Label for CVRx Barostim System in HF - Vimarsana News

FDA Expands Label for CVRx Barostim System in HF

The Barostim neuromodulation system is now indicated in NYHA class III or class II HF despite guideline-directed medical therapies, with LVEF ≤ 35% and NT-proBNP < 1600 pg/mL.